HR 4392
115th Congress
House
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating…
Official title: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Repor… Show full official titleShow less
Official title: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesHealth care costs and insuranceHome and outpatient care
More subjectsShow fewer subjects
Hospital careInflation and pricesMedicarePrescription drugs
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2017
Referred to the Subcommittee on Health.
Nov 14, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 14, 2017
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cosponsors
130
Roby, Martha
King, Steve
D
Cleaver, Emanuel
D
Veasey, Marc A.
D
Aguilar, Pete
R
Crawford, Eric A. "Rick"
R
Calvert, Ken
D
Watson Coleman, Bonnie
D
Castro, Joaquin
GUTIERREZ, LUIS
D
Norcross, Donald
D
Peters, Scott H.
D
Keating, William R.
R
Smith, Christopher H.
R
Bacon, Don
D
Boyle, Brendan F.
D
Huffman, Jared
Knight, Stephen
LOBIONDO, FRANK
D
Green, Al
D
Adams, Alma S.
D
Sánchez, Linda T.
D
McCollum, Betty
BRADY, ROBERT
D
DelBene, Suzan K.
Abraham, Ralph
D
Garamendi, John
R
Aderholt, Robert B.
D
Himes, James A.
R
Curtis, John R.
Mitchell, Paul
Rothfus, Keith
Lujan Grisham, Michelle
D
Jayapal, Pramila
D
Jeffries, Hakeem S.
R
Johnson, Mike
R
Kelly, Trent
Love, Mia
D
Smith, Adam
R
Smucker, Lloyd
D
Thompson, Bennie G.
DUNCAN, JOHN
Faso, John
Marino, Tom
D
Pingree, Chellie
R
Wittman, Robert J.
D
Khanna, Ro
Reichert, David
R
Rogers, Mike D.
Shuster, Bill
Page 1 of 3
Next
Cite this page
U.S. Congress. (2026). H.R. 4392: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4392/
"H.R. 4392: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4392/.
H.R. 4392, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4392/.
[H.R. 4392: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.](https://openamerica.io/bill/115-HR-4392/)